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Summary 
The role that potassium channels play in human T lymphocyte activation has been investigated 
by using specific potassium channel probes. Charybdotoxin (ChTX), a blocker of small conductance 
Ca  2  +-activated potassium channels (Pc,c,) and voltage-gated potassium channels (PK,v) that are 
present in human T  cells, inhibits the activation of these cells. ChTX blocks T  cell activation 
induced by signals (e.g., anti-CD2, anti-CD3, ionomycin) that elicit a rise in intracellular calcium 
([Ca2+]i) by preventing the elevation of [Ca2+]i in a dose-dependent manner. However, ChTX 
has no effect on the activation pathways (e.g., anti-CD28, interleukin 2 [IL-2]) that are independent 
of a rise in [Ca2+]i. In the former case, both proliferative response and lymphokine production 
(Ib2 and interferon 3') are inhibited by ChTX. The inhibitory effect of ChTX can be demonstrated 
when added simultaneously, or up to 4 h after the addition of the stimulants. Since ChTX inhibits 
both PK,C~ and Pg.v. we investigated which channel is responsible for these immunosuppressive 
effects with the use of two other peptides, noxiustoxin (NxTX) and margatoxin (MgTX), which 
are specific for Pg,  v. Theses studies demonstrate that, similar to ChTX, both NxTX and MgTX 
inhibit  lymphokine production  and  the rise in  [Ca2+]i.  Taken  together,  these data provide 
evidence that blockade of PK,V affects the Ca2+-dependent pathways involved in T  lymphocyte 
proliferation and lymphokine production by diminishing the rise in [Ca2+]i that occurs upon 
T  cell activation. 
T 
he activation of T  lymphocytes via antigen receptor is 
associated  with phosphotidylinositol turnover and an 
increase in intracellular Ca  2+  ([Ca  2+ ]i) 1. Although part of 
this rise in [Ca2+]i appears to depend upon Ca  2+ influx, the 
precise mechanism responsible for elevation of [Ca2+]i re- 
mains to be determined (1). In addition to Ca  2+ influx, T 
cell activation results in enhanced K § efflux. The predomi- 
nant K + channel in human T lymphocytes is a voltage-gated 
channel (Pz.v) (2, 3) that has properties similar to a delayed 
rectifier K + channel of nerve cells which has been cloned 
(4-8). Human T cells also possess a variety of small conduc- 
tance Ca  2  +-activated K + channels (PK,c,) that have recently 
1 Abbreviations  used in this paper: ol-DaTX, o~-dendrotoxin;  [Ca  2  +  ]i, intra- 
cellular Ca  2+ concentration; ChTX, charybdotoxin; 4-AP, 4-aminopyr- 
idine;  IbTX, iberiotoxin;  InsP3, Inositol-l,4,5-triphosphate;  MgTX, 
margatoxin; NxTX, noxiustoxin; PK,ca, Ca2+-activated potassium chan- 
nd; Pg,v, vohage-gated potassium channel; TEA, tetraethylammonium. 
been characterized (9).  A  link between the rise in [Ca2+]i 
and the function of these K + channels is not completely un- 
derstood. 
The  rise  in  [Ca2+]i  via  receptor-operated  channels  or 
second messenger pathways is dependent on membrane poten- 
tial.  Lymphocyte membrane depolarization has been shown 
to result in an inhibition of mitogen-activated Ca  2+ uptake 
(10), as well as anti-CD3- and anti-CD2-induced increase 
in [Ca2+]i in human T lymphocytes (11, 12) or Jurkat cells 
(13). [Ca  2+ ]i elevation induced by thapsigargin, an inhibitor 
of the endoplasmic reticulum Ca  2  +-ATPase, is also prevented 
when lymphocytes are depolarized (10,  14). 
Evidence for the involvement of K + channels in T cell ac- 
tivation comes from experiments demonstrating that agents 
known to block K + channels inhibit this process (10). PHA- 
stimulated human T cell activation as measured by IL-2 produc- 
tion, proliferation, and protein synthesis was shown to be 
inhibited by the nonselective K §  channel blockers,  tetra- 
ethylammonium (TEA) and 4-aminopyridine (4-AP) (15). 
TEA was also reported to inhibit elevation in [Ca2+]i (16). 
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sary to cause these effects are very high (mM range), and there- 
fore their effects on T  cell activation could be nonspecific 
(17). Charybdotoxin (ChTX), a 37-amino acid peptide iso- 
lated from venom of the scorpion Leiurus quinquestriatus var. 
hebraeus (18), blocks with high affnity both P~r  in human 
lymphocytes (9) and PK,v in T lymphocytes from several spe- 
cies (19). The effect of ChTX on human lymphocyte activa- 
tion has been reported by several groups, but with conflicting 
results.  For example,  Price et al.  (20) and Bono et al. (21) 
demonstrated that ChTX inhibited PHA-stimulated T  cell 
proliferation and Ib2 production. Gelfand and Or (22), how- 
ever, reported that ChTX inhibited cell membrane hyperpolar- 
ization in T  lymphocytes stimulated by PHA, but had no 
effect on the proliferative response.  Thus, the putative role 
of K +  channels  in  controlling  T  cell  activation remains 
unclear. 
To address this issue,  the effects of a variety of peptidyl 
K + channel inhibitors on different activation parameters  in 
human T cells have been investigated. In this study, we dem- 
onstrate that ChTX inhibits T  cell activation, as measured 
by either proliferation or lymphokine production, when trig- 
gered by pathways associated with a rise in [Ca~+]i. In this 
respect,  the action of ChTX is remarkably similar to that 
of cyclosporin A and FK-506 (23). Since ChTX inhibits both 
PK,c, and PK,v, the effects of several selective Pi~,v blockers, 
such as noxiustoxin (NxTX) (5, 9) and the recently isolated 
peptide margatoxin (MgTX) (9, 24), were also investigated 
on T cell activation to discern which channel is responsible 
for the profile obtained with ChTX. With the use of these 
peptidyl inhibitors,  we conclude that blockade of Pz,v is 
sufficient  to  inhibit  human  T  cell  activation.  This  PK,v 
inhibition appears to cause membrane depolarization (9) which 
in  turn blocks  the rise  in  [Ca2+]i.  These results confirm 
and extend the data of others by identifying PK,V as the rele- 
vant ion channel for the in vitro immunosuppressive effects 
of ChTX. 
Materials and Methods 
Reagents.  ChTX was purified to homogeneity from the scor- 
pion L. quinquestriatus vat. hebraeus  obtained from Alomone Labora- 
tories (Jerusalem, Israel) (18). Synthetic NxTX was generously 
provided by Dr. R. Nutt (Merck Research  Laboratories,  West Point, 
PA). Iberiotoxin (IbTX) was isolated from Buthus tamulus venom 
as described (25). c~-Dendrotoxin  (cr  was a gift of Dr. M. 
Blaustein (University of Maryland, Baltimore, MD). MgTX was 
isolated from venom of the scorpion Centruroides margaritatus (24). 
All peptides were stored lyophylized  at - 70~  Before the experi- 
ments, the peptides were reconstituted to 10/xM in Tris buffer 
(20 mM Tris/HC1, 100 mM NaC1, pH 7.4) with 0.1% BSA also 
present. FK-506 was isolated from Streptomyces tsukubaensis by Dr. 
R. Borris (Merck Research Laboratories). FK-506 was dissolved 
at 1 mg/mL in ethanol and stored at -70~  PMA (Sigma Chem- 
ical Co., St. Louis, MO) and ionomycin (Calbiochem Corp., San 
Diego, CA) were dissolved  at 10/~g/ml and I mg/ml, respectively, 
in dimethyl sulfoxide and stored at  -70~  Recombinant human 
Ib2 was obtained from Amgen Biologicals  (Thousand Oaks, CA). 
OKT3 (anti-CD3) mAb was obtained from Ortho Diagnostic 
Systems (Raritan, NJ). Affinity-purified  rabbit anti-mouse IgG was 
obtained from Cappel (Organon Teknika  Corp., West Chester, PA) 
Anti-CD28 (mAbs 9.3) was a gift from Drs. J. A. Ledbetter  (Genetic 
Systems, Seattle, WA) and C. June (Naval Medical Research Insti- 
tute, Bethesda, MD). Anti-CD2 mAbs Tll.2 and Tll.3 were gifts 
from Dr. E. Reinhertz (Harvard Medical School, Boston, MA) 
CellPreparations.  PBMC were isolated from heparinized  blood 
samples of normal donors using lymphocyte separation medium 
(LSM; Litton Bionetics, Kensington, MD) density gradient cen- 
trifugation followed  by lysis  of  erythrocytes  with ACK lysing  buffer 
(Gibco, Grand Island, NY). Highly purified T lymphocytes were 
further isolated by nylon wool as described previously (23). 
Proliferation Assays.  Highly purified T lymphocytes were cul- 
tured in triplicate  samples in flat-bottomed, 96-well  microtiter plates 
(Costar, Cambridge, MA) at 2  x  105 cells per well in complete 
medium consisting of RPMI 1640 medium (Gibco) supplemented 
with 10% heat-inactivated  FCS (Hyclone  Laboratories,  Logan, UT), 
2 mM t-glutamine, 100/xM nonessential  amino adds, 20/zM 2-ME, 
100 U/ml penicillin, and 100/~g/ml streptomycin. The cultures 
were stimulated  with  anti-CD2  (Tll.2  +  Tll.3),  anti-CD3 
(OKT3), anti-CD28 (9.3), or ionomycin, with or without PMA. 
Either ChTX,  NxTX,  c~-DaTX, IbTX, or FK-506 at indicated 
concentrations, was added at the beginning  of the incubation. 
The cultures were incubated for 2 d at 37~  in a 5% CO2 at- 
mosphere, and T cell proliferation was measured by addition of 
[3H]thymidine (6.7 Ci/mmol, New  England Nuclear, Boston, 
MA) to each culture (2/~Ci per well), 4 h before harvesting. Cul- 
tures were harvested  on glass fiber filters  using a cell harvester (Ska- 
tron,  Inc., Sterling, VA). Radioactivity was measured using the 
Betaplate Liquid Scintillation  System  (model 1205; Pharmacia  LKB 
Nuclear Microtomy Inc., Gaithersburg, MD). All data are shown 
as the means of triplicate cultures. 
Mixed Lymphocyte Reaction.  PBMC were cultured in triplicate 
samples in round-bottomed, 96-well microtiter plates (Costar) at 
2.5  x  10  s cells per well in complete media as described for the 
proliferation assay. Equal amounts of irradiated mononuclear cells 
from a second individual were added to the cultures as stimulator 
cells. FK-506, ChTX, NxTX, c~-DaTX, and IbTX, at indicated  con- 
centrations, were added at the beginning of the cultures. The cul- 
tures were incubated at 37~  in a 5% CO2 atmosphere. T cell 
proliferation was measured as described for the proliferation assay. 
12sI-ChTX Binding Assay.  To characterize the interaction of 
NxTX, c~-DaTX, and IbTX with the human T cells used in this 
study, we tested the ability of these peptides to compete for the 
binding of 12sI-ChTX to the preparation as previously described 
(26). Briefly, monocyte-depleted, E-rosetted lymphocytes (2.5  x 
106 cells/ml, 0.4 ml per tube) were incubated in  12  x  75-mm 
polystyrene tubes with 5 pM nsI-ChTX in the absence or pres- 
ence of increasing concentrations of various toxins. The binding 
assay is carried out in isotonic sucrose medium containing 10 mM 
Hepes, 5 mM KC1, 5 mM NaC1, and 6 mM glucose, pH 7.4. The 
reaction mixtures were incubated for 1 h at room temperature on 
a rotary shaker. At the end of the incubation period, the samples 
were diluted with 4 ml of cold quench solution (200 mM NaC1, 
20 mM Hepes, titrated to pH 8 with Tris-base) and faltered  through 
glass microfiber filters (GF/C; Whatman Inc., Clifton, NJ) that 
had been presoaked in 0.6% polyethylenimine.  Nonspecific  binding 
was determined in the presence of 10 nM ChTX. Each data point 
represents the average of triplicate samples. 
Measurement of lL2 and IFN-7 Production.  Lymphocytes  were 
cultured in triplicate wells of 96-well microtiter plates and stimu- 
lated with OKT3 or ionomycin and PMA. Supernatants were col- 
lected 4 or 24 h after the initiation of cultures. The Ib2 level in 
each supernatant was measured using the IL-2 ELISA assay  system 
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using a KIA assay system (Centocor, Philadelphia,  PA). 
Measurement of[Caa+]i.  Most of the flow cytometric [Ca2+]i 
determinations were performed as previously described (23). Purified 
lymphocytes were washed with RPMI 1640 buffered with 10 mM 
Hepes, pH 7.4. The pellet was resuspended at 2  x  10  s cells/ml 
in RPMI-Hepes containing 1 #M indo-1 AM (Molecular Probes, 
Inc., Eugene, OK) and incubated 45 min at 37~  in the dark. The 
cells were then subjected to centrifugation, resuspended in  the 
original volume of RPMI-Hepes and incubated an additional 45 
min  at  37~  in  the dark.  After centrifugation,  the cells were 
resuspended in RPMI-Hepes at 2  x  106 cells/ml and maintained 
in the dark at room temperature until analysis. A FACS  |  Ana- 
lyzer/Consort 30 equipped with a 55-megabyte hard disc/tape drive 
(Becton Dickinson Immunocytometry Systems, San Jose, CA) was 
adapted to measure intracellular Ca  2§  using indo-1.  An increase 
in [Ca2+]i was detected with indo-1  as an increase in the ratio of 
a lower to a higher emission  wavelength (405 nm/485 nm emis- 
sion) which is proportional to the internal calcium level. Since no 
standardization curve was determined to correlate intracellular cal- 
cium concentration with indo-1 ratio, the data are expressed as rel- 
ative [Ca2+]i. Indo-loaded lymphocytes were incubated with pep- 
tides at 37~  for 15 rain. OKT3 (10 ng/ml) was added and the 
[Ca2+]i  response  was  monitored  for  3-4  min,  before  rabbit 
anti-mouse IgG antibody (40 #g/ml) was added. In some experi- 
ments, ionomycin (125 ng/ml) was added and the [Ca2+]i response 
was measured. For the membrane depolarization  experiments using 
high potassium buffers, the appropriate buffer was also used as sheath 
fluid. In more recent experiments, data from the FACS  |  Analyzer 
sensor  head  were  collected as  a  continuous  file  into  Consort 
40/#VAX computer system via a FACS  |  Data Lister (Becton Dick- 
inson).  Mean  [Ca2+l, time  course  data  were  displayed  using 
KINPRO Software (Becton Dickinson & Co.). 
Measurement of Inositol-1,4,5-Trisphosphate  (InsPs).  Purified  T 
lymphocytes were suspended at 2  x  107/ml in 0.5 ml of HBSS 
containing 20 mM Hepes (pH 7.4) and 0.1% FCS in microfuge 
tubes, and preincubated with OKT3 (1 #g/ml) at 4~  for 5 min. 
All tubes were transferred to a 37~  waterbath and incubated for 
2 min. Cells were then activated by adding rabbit anti-mouse IgG 
antibody (40/~g/ml). The reaction was terminated at the indicated 
times by adding 0.2 volumes of ice-cold 100% TCA solution. The 
concentration of InsP3 in each sample was quantified by using a 
radioreceptor assay kit (Dupont,  Wilmington,  DE). 
Results 
ChTX  Only Inhibits T  Lymphocyte Proliferation and Lym- 
IOhokine Production Stimulated by Signal Transduction Pathways 
Associated with a Rise in [Ca2+~.  Proliferation of T  lympho- 
cytes can be induced by antibodies  specific for a variety of 
cell surface molecules. To study the effects of ChTX on these 
pathways,  highly purified T  cells were stimulated  with ei- 
ther anti-CD2 antibodies (T11.2/Tll.3), anti-CD3  +  PMA 
or ionomycin  +  PMA, all of which trigger a rise in [Ca  2+ ]~. 
Alternatively, experiments were performed with either anti- 
CD28  +  PMA or IL-2  +  PMA,  which induce T  cells to 
enter the cell cycle without  inducing  a  measurable rise in 
[Ca  2+ ]i. FK-506 served as a positive control in these experi- 
ments (23). The results in Table 1 suggest that ChTX produces 
the same pattern of inhibition as FKo506. Thus,  ChTX in- 
hibits proliferative responses induced by anti-CD3  +  PMA 
or ionomycin +  PMA, but had no effect on II~2 +  PMA-in- 
duced proliferation. Therefore, ChTX only inhibits pathways 
that  are associated with  a rise in  [Ca2+]t. 
We next examined the effect of ChTX on IL-2 production 
using the distinct activation pathways previously described. 
Lymphocytes, preincubated with ChTX at 37~  for 15 rain, 
were stimulated with anti-CD3  +  PMA or anti-CD28  + 
PMA,  and supernatants were collected after 24 h  for deter- 
mination of II.-2.  As shown in Fig.  1,  ChTX inhibits  Ib2 
production  stimulated  by  anti-CD3  +  PMA  in  a  dose- 
dependent manner, whereas I/_-2 production of lymphocytes 
stimulated  by anti-CD28  +  PMA  is unaffected. 
Table  1.  Effect  of ChTX on T Lymphocyte Proliferation Stimulated by Various Pathways 
[3H]Thymidine uptake 
Culture  CD2  CD3/PMA  Ion/PMA  IL-2/PMA  CD28/PMA 
cpm 
Expt.  1 
Control  43,431  47,888  ND  ND  ND 
ChTX  18,899  20,058  ND  ND  ND 
FK-506  850  2,201  ND  ND  ND 
Expt. 2 
Control  ND  ND  87,069  62,325  117,713 
ChTX  ND  ND  35,738  62,879  123,581 
FK-506  ND  ND  5,788  65,732  135,864 
T lymphocytes (10~/ml, 0.2 ml/well) were cultured in 96-wall plates. ChTX or FK-506 was added at a final concentration of 10 nM. Different 
stimulants were then added to the cultures as indicated. The final concentration of PMA was 1 ng/ml; anti-CD3, 10 ng/ml; Ionomycin, 250 ng/ml; 
IL-2, 10 U/ml; anti-CD28, 10 ng/ml; anti-CD2:T11.2,  84/~g/ml,  and Tll.3, 56/tg/ml. The cultures were incubated for 2 d and [3H]thymidine 
incorporation determined. All data are shown as the means of triplicate cultures. SD for each data point is <5%. 
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Figure  1.  Effect of ChTX on the lymphokine production of activated 
T cells.  Lymphocytes (3  x  106/ml, 0.2 ml/well) were cultured with ap- 
propriate concentration  of ChTX in 96-weU plates with anti-CD3 (5 ng/ml, 
O) or anti-CD28 (200 ng/ml, 0), and PMA (3 ng/ml). Supernatants were 
collected after 24-h incubation, and the II,-2 level for each supernatant de- 
termined. Data are expressed as percent control. Control culture contains 
55 U/ml oflb2 for anti-CD3/PMA and 154 U/ml for anti-CD28/PMA. 
All data are shown as the means of triplicate  cultures.  SD for each data 
point is <5%. 
ChTX Inhibits at an Early Stage of T Cell Activation.  To 
investigate the kinetics of the inhibitory effect of ChTX on 
proliferation,  ChTX or FK-506 was added to the lympho- 
cyte cultures at different times after stimulation with anti- 
CD2 antibodies, Tll.2 and Tll.3. Data shown in Fig. 2 sug- 
gest that ChTX is less effective if added 4 h after activation. 
Minimal inhibition  is observed if ChTX or FK-506 is added 
18 h after T cell stimulation.  These data imply that ChTX, 
similar to FK-506, exerts its antiproliferative effect at an early 
step in T  cell activation. 
ChTX  Inhibits  Mitogen-induced  Rise  In  [Ca2+]+.  Since 
ChTX inhibits activation pathways that are associated with 
a rise in [Ca  2+ ]~, we examined the effect of ChTX  on the 
increase in  [Ca  2+]i of anti-CD3-stimulated  lymphocytes. 
Data in Fig.  3 A  demonstrate that the inhibitory  effect of 
ChTX  on anti-CD3-induced increase in [Ca  2+ ]i was dose 
dependent and that ChTX seems to inhibit the early but not 
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Figure  2.  ChTX inhibits at an 
early stage of T cell activation.  T 
lymphocytes (10+/ml, 0.2 ml per 
well)  were  cultured  in  96-well 
plates.  The cultures were stimu- 
lated with anti-CD2 antibodies, 
Tll.2 (84/zg/ml) and Tll.3 (65 
#g/ml), and incubated at 37~ 
ChTX (10 nM,[]) or FK-506 (10 
nM,  k~) was added  at  different 
times as indicated.  Proliferation 
was determined by [3H]TdR in- 
corporation  2  d  later.  Control 
proliferative response was 127,844 
cpm.  All data are shown as the 
means of triplicate cultures. SD for 
each  data point is <5%. 
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Figure  3.  Effect  of ChTX  on 
the rise in [Ca  z + ]i of activated T 
cells. Lymphocytes were preloaded 
with indo-1 and then pteincubated 
with or without different concen- 
trations of ChTX for 15 min at 
37~  OKT3 (5 ng/ml) and rabbit 
anti-mouse  IgG (40  /~g/ml)  or 
ionomycin  (125  ng/ml)  were 
added and measurment  of relative 
[Ca2+]i  was  performed  on  the 
FACS |  analyzer  as described  in 
Materials and Methods.  (A) Dose- 
dependent effect of ChTX on the 
rise in [CF+]i of OKT3 activated 
T  cells.  (Arrow) Point at  which 
rabbit anti-mouse IgG was added. 
Control (  ); ChTX,  10 nM 
(  ....... ); 100 nM (- -  -). (B) ~ffect 
of ChTX on ionomycin induced 
rise in  [CaZ+]i. Ionomycin  was 
added at time 0. Control (  -  ); 
ChTX,  100 nM (---). 
the late, sustained phase of [Ca  2  + ]i elevation. Preincubation 
with ChTX did not induce changes in normal [Ca2+]i levels. 
Similarly, ChTX also inhibits ionomycin-induced  elevation 
in [Ca2+]i (Fig. 3 B).  Our results demonstrate that ChTX 
exerts its effects by blocking the [Ca  2  +]i increase associated 
with T  cell activation. 
ChTX  Has  No  Effect on  Mitogen-induced  InsP~ Produc- 
tion.  Since ChTX was shown to inhibit the early phase of 
[Ca2+]i elevation, which is believed to be associated with the 
release of Ca from internal stores by InsP3 (1), we next tested 
whether  inhibition  of OKT3-induced  rise in  [CF+]i  by 
ChTX could be due to its inhibitory effect on the production 
of InsP3. Kinetic studies showed that when T cells were in- 
cubated with OKT3  and rabbit anti-mouse IgG,  the level 
of InsP3 induced  increased rapidly, and  reached the  peak 
around 60 s after activation. Results shown in Table 2 indi- 
cate that ChTX preincubation did not inhibit  the produc- 
tion of InsP3 in OKT3-stimulated  T  cells. 
P~,v Is the Relevant  Target  for the Immunosuppressive Effects 
of ChTX.  Since ChTX  blocks  both  Pz.c,  and  PK.v in 
human  T cells (9), we wished to investigate whether blockade 
of one or both of these channels was necessary for the im- 
munosuppressive effects observed with the peptide.  NxTX 
and IbTX are peptides purified from other scorpion venoms 
which share 40 and 68% sequence homology with ChTX, 
respectively. NxTX inhibits only ChTX-sensitive Pz.v, but 
not PK.c, in human T lymphocytes  (9).  IbTX consists of a 
single 4.3-kD polypeptide chain and selectively inhibits the 
high conductance Pz.ca in smooth muscle. This peptide does 
not block ChTX-sensitive  PK,ca or PK,V in lymphocytes  (9, 
26). ot-DaTX is a weak blocker of Pz,v in lymphocytes (26). 
As shown in Fig. 4 A, NxTX and a-DaTX inhibit the binding 
of t2sI-ChTX to Pz.v in lymphocytes,  whereas IbTX has no 
effect. These results are consistent with previously reported 
data indicating that t~sI-ChTX binding is a monitor of PK,v 
in human T  cells (26). 
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Expt.  No.  Culture  InsP~, picomole 
1  Control  15.05 
ChTX,  100 nM  15.85 
2  Control  22.0 
ChTX,  100 nM  18.6 
Purified T lymphocytes were suspended at 2  x  107 cells/m1 in 0.5 ml 
of HBSS containing  20 mM Hepes (pH 7.4) and 0.1% FCS in microfuge 
tubes, and preincubated with OKT3 (1 #g/ml) at 4~  for 5 min. All 
tubes were  transferred  to a 37~  waterbath and incubated  for 2 min. 
Cells were then activated by adding rabbit anti-mouse IgG antibody (40 
/zg/ml). The reaction was terminated at 60 s by adding 0.2 volumes of 
ice-cold 100% TCA solution. The concentration of InsP3 in each sam- 
ple was quantitated by using a radioreceptor  assay kit (Dupont, Wil- 
mington, DE).  The results are expressed as pmol per 107 cells. 
The dose-response curves of ChTX, NxTX, oe-DaTX, and 
IbTX on anti-CD3  +  PMA-induced proliferation are shown 
in Fig.  4 B. ChTX and NxTX inhibit this proliferative re- 
sponse with IC50 of 3 and 8 nM, respectively, whereas IbTX 
has no effect. The rank order of potency of these peptides 
in blocking T cell proliferation (Fig. 4 B) correlates well with 
their rank order in competing for the binding of 12sI-ChTX 
to PK,v in lymphocytes (Fig. 4 A). These results further sup- 
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Figure 4.  Pg.v is the relevant target for the immunosuppressive effects 
of ChTX. (.4) 12sI-ChTX competition binding assay. Assays were con- 
ducted in 12  x  75-mm polystyrene tubes. The assays contained 5 pM nsI- 
ChTX, toxins, at different concentrations as indicated (ChTX, O; NxTX, 
N; ~-DaTX, A; IbTX,  ,)  and lymphocytes (2.5  x  106 cells/ml,  0.4 
ml per tube) which were suspended in isotonic sucrose medium containing 
10 mM Hepes, 5 mM KC1, 5 mM NaC1, and 6 mM glucose, pH 7.4. 
The mixtures were incubated for 1 h at room temperature  and assayed 
as described. Each data point represents the average of triplicate samples 
minus nonspecific binding which was determined in the presence of 10 
nM ChTX. (B) Dose-dependent  effect of K + channel blockers on anti- 
CD3  and PMA induced proliferation.  Highly purified T  lymphocytes 
(2 x  106/ml, 0.2 ml per well) were cultured in flat-bottomed  wells of a 
96-well microtiter plate. K + channel blockers were added to the cultures 
at concentrations as indicated. OKT3 (5 ng/ml) and PMA (1 ng/ml) were 
added to each well. Cultures were incubated for 2 d and [3H]TdR incor- 
poration for each culture was determined  as described in Materials and 
Methods. The proliferative  response for the control was 20,736 cpm. ChTX, 
O; NxTX, [~; c~-DaTX, A; IbTX, II. All data are shown as the means 
of triplicate cultures.  SD for each data point is <5%. 
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Figure 5.  ChTX  and  NxTX  inhibit MLR.  T  lymphocytes  (4  x 
106/ml) were cultured in U-shape bottomed wells (0.1 ml/well) of the 
96-well plates. Irradiated mononuclear leukocytes (4  x  106/ml) from a 
second individual were added (0.1 ml per well) as stimulator cells. The 
cultures were incubated with ChTX (O), NxTX (V]), or FK-506 (A) at 
the concentrations indicated. Proliferation was measured by [3H]TdtL in- 
corporation 4 d later. The proliferative response for the control (O) was 
57,000 cpm. All data are shown as the means of triplicate cultures. SD 
for each data point is <5%. 
port the notion that blockade of PK.v is sufficient to inhibit 
T cell activation. The difference in the absolute potencies of 
the peptides in the two assays is most likely due to the fact 
that binding experiments are carried out in low ionic strength 
buffer, whereas proliferation effects are monitored in physio- 
logical culture media (26). 
We next tested the effect of ChTX and NxTX on a MLR 
in  order  to  better  understand  if  blockade  of  Pg.v  can 
influence T cell function after activation by a more physio- 
logically relevant stimuli. Using this protocol, we found that 
both ChTX and NxTX inhibit the MLR in a dose-dependent 
manner (Fig.  5).  The ICs0 for both  agents  are similar to 
those found in blocking anti-CD3  +  PMA-induced prolifer- 
ation (Fig, 4 B). These results illustrate that PK,v is the rele- 
vant target for the immunosuppressive effect of ChTX. 
Blockade of PK, v Inhibits Lymphokine Production.  We have 
previously demonstrated (Fig.  1)  that  ChTX inhibits  IL-2 
! 
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Figure 6.  Blockade of PK,V inhibits 
lymphokine production. T lymphocytes 
(10?/ml,  1 ml/we11) were  cultured  in 
each well of the 24-well plates. Com- 
pounds tested were added at a final con- 
centration of 10 nM.  lonomycin (250 
ng/ml) and PMA (10 ng/ml) were then 
added to the cultures. Supernatants were 
collected from each culture 4 h later and 
IL.2 and IFN-3/levels were determined. 
Data are expressed as percent control. The 
IL-2 level  in control was 450 U/ml. IFNw 
level  in the control culture was 50 U/m1. 
All data are shown as the means of tripli- 
cate  cuhures.  SD  for  each data  point 
is <5%. production stimulated by anti-CD3  +  PMA. To determine 
whether other pathways that generate a rise in [Ca  2+]i are 
affected by PK.v inhibition,  the effects of toxins  on lym- 
phokine production were investigated after T cell stimula- 
tion with ionomycin +  PMA. For this experiment, larger 
numbers of cells per culture were used and supernatants were 
collected  4 h after the addition of the stimulus. ChTX, NxTX, 
c~-DaTX, and IbTX were each tested at 10 nM. ChTX and 
NxTX, but not o~-DaTX or IbTX inhibit II.-2 (Fig. 6 A) and 
IFN-3, (Fig. 6 B) production by ionomycin +  PMA-stimu- 
lated lymphocytes. These results are consistent  with those 
found in proliferation and binding assays. Whereas ol-DaTX 
is a weak inhibitor of binding, it had no effect on either 
proliferation or lymphokine production at a concentration 
of 10 nM. 
The role of PK,V in lymphokine production was further 
supported  by studying the newly isolated peptide  MgTX. 
Electrophysiological data indicate that MgTX is a more po- 
tent inhibitor of the human T lymphocyte PK,V than either 
ChTX or NxTX, and it has no effect on the ChTX-sensitive 
PK,Ca of lymphocytes  (9). The  effect of MgTX  on  IL-2 
production of ionomycin +  PMA-stimulated T lymphocytes 
was determined.  As shown in Table 3, MgTX inhibits  IL-2 
production of activated lymphocytes and, as predicted,  ap- 
pears to be more potent than ChTX. 
NxTX and MgTX Inhibit Mitogen-induced Rise in [Ccl2+]i. 
To further determine whether NxTX, o~-DaTX, IbTX, and 
MgTX would effect the rise of [Ca2+]i induced by anti-CD3 
as previously demonstrated for ChTX, this parameter of T 
cell activation was monitored. As shown in Fig. 7 A, 100 
nM NxTX blocks the increase in [Ca2+]i,  as does ChTX, 
whereas 100 nM oe-DaTX has little or no effect. IbTX at 100 
nM, which has no effect on T cell proliferation,  also has no 
effect on the rise in  [Ca2+]i  (data not shown). Consistent 
with its potency in blocking PK.V and lymphokine produc- 
tion,  MgTX  is  the most  potent inhibitor  of the rise  in 
[Ca2+]i of all the toxins used in this study (Fig. 7 B). These 
Table 3.  Effect of MgTX on IL-2 Production 
Culture  nM  IL-2 
Control 
ChTX 
MgTX 
2  nM 
20  nM 
0.5  nM 
5  nM 
U/ml 
75.0  +  12.0 
31.2  +  1.4 
2.8  +  0.2 
12.0  +  0.4 
8.2  +_  0.5 
Lymphocytes  (3  x  106/ml,  0.2 ml per well) were cultured in 96-well 
plates with various concentrations  of ChTX or MgTX. Ionomycin (250 
ng/ml) and PMA (1 ng/ml) were then added to the cultures.  After 24-h 
incubation,  supernatants  were collected and IL-2 levels determined.  All 
data  are shown as the means  of triplicate  cultures. 
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Figure  7.  NxTX and MgTX inhibit the rise in [Ca  2  + ]i of activated T 
cells. Lymphocytes were preloaded with indo-1 and then preincubated with 
or without different concentrations  of (A) c<-DaTX, NxTX; (B) MgTX 
for 15 min at 37~  OKT3 (10 ng/ml) and anti-Ig 1:50 dilution were 
added and measurement  of relative [Ca  2  +  ]i was Performed on the FACS  | 
analyzer as described in Materials and Methods.  (Arrow) Time point at 
which the second antibody was added. Control (  ) (,4) o<-DaTX, 100 
nM ( ..... ); NxTX, 100 nM (---) and ChTX, 100 nM (- - -); (B) MgTX, 
0.3  nM ( ..... ); 3 nM (---). 
results  suggest  that blockade  of Pz.v prevents the rise in 
[Ca2+]i  normally associated with activation  via the TCR 
complex. 
Lymphocyte Depolarization Blocks the Activation-induced  Rise 
in [Ca2+]i.  Since  ChTX  has been reported to  depolarize 
human T cells (9, 27), we hypothesized that ChTX may in- 
hibit  the rise in [Ca  2+]i by its effect on the lymphocyte's 
resting potential.  To further investigate the relationship be- 
tween membrane potential and [Ca  2+ ]i, we altered the cell's 
resting potential in a manner that is independent of  blockade 
of PK,V. When lymphocytes are suspended in high K + so- 
80 
70  ._ 
";"  6o 
.~  so 
~  40 
30 
I  I  I 
20  100  200  300  400 
Time (sec) 
Figure  8.  Effect of membrane depolarization  on calcium levels of acti- 
vated lymphocytes. Indo-l-loaded lymphocytes in PBS (  .... ) or 80 mM 
K + solution  (---) were stimulated  with OKT3 (10 ng/ml) and  anti-Ig 
(1:50 dilution),  and measurement of relative [Ca2+]i was performed as de- 
scribed. In the same experiment,  the effect of ChTX (100 nM) was also 
measured  in PBS ( ..... ) or in 80 mM K + (data not shown).  The zero 
point represents  the point at which second antibody  was added. 
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Therefore, we examined the effect of changes in membrane 
potential  on  the rise in  [CaZ+]i of lymphocytes activated 
by anti-CD3 in high K + medium. Fig.  8  shows that the 
[Ca  z +  ]i increase induced by anti-CD3 is inhibited when cells 
are suspended in high K + solutions. Inhibition of both the 
transient increase and the sustained plateau are similar in mag- 
nitude to those observed in the presence of a maximal con- 
centration of ChTX. As expected, addition of ChTX in 80 
mM K § does not have an additive effect (data not shown). 
Discussion 
The results presented in this paper demonstrate that ChTX, 
an inhibitor of Pz.v and small conductance PK,Ca in human 
T  cells,  blocks the proliferative response and lymphokine 
production of T cells activated only by pathways that induce 
a rise in [Ca2+]i, such as those stimulated by anti-CD3, anti- 
CD2, or ionomycin +  PMA. ChTX exerts its immunosup- 
pressive  effect in a specific manner since the block in II.-2 
production can be bypassed if the cells are activated via the 
biochemically distinct CD28 pathway. Furthermore, the ability 
of ChTX to inhibit a MLR implies that a variety of antigen- 
specific responses may be susceptible to inhibition through 
this toxin-sensitive pathway. With respect to its selectivity 
for certain types of lymphocyte activation pathways, the im- 
munosuppressive properties of ChTX are indistinguishable 
from those of FK-506 and cyclosporine. The sites of action 
of these immunosuppressants are distinct, however, since FK- 
506 and cyclosporine interfere with a cytosolic, Ca2+-asso - 
ciated signaling process,  and do not have a direct inhibitory 
effect on the rise in [Ca2+]i (23). 
PK,v has been demonstrated to be the predominant K § 
channel in human T lymphocytes, and its gating properties, 
conductance, kinetics, and selectivity have been well charac- 
terized (2, 3). More recently, human lymphocyte PZ,Ca have 
also been identified and characterized (9).  The possible in- 
volvement of these K § channels in T cell activation has been 
addressed by different investigators. Early studies suggesting 
a role for PK,v were not conclusive because the high concen- 
trations of the nonselective K § channel blockers TEA and 
4-AP required to show inhibition of T cell proliferation may 
have interfered with cellular processes nonspecifically. Specific 
K § channel toxins have provided an important tool for in- 
vestigating the role of K § channels in T  cell activation. In 
this respect, previous studies have shown that PHA-induced 
proliferation was inhibited by ChTX, and that the inhibitory 
effect of ChTX was at the level of IL-2 production (20). 
Since ChTX  inhibits  both  Pz.ca  and  Pz.v  in human T 
lymphocytes, blockade of either one or both of these channels 
may be sufficient to interfere with T cell activation. This ques- 
tion was directly addressed pharmacologically by the use of 
peptides that are selective for Pz.v. Electrophysiological data 
have shown that NxTX and MgTX are selective inhibitors 
of PK,v in that they do not block Pz,c, in human T  lym- 
phocytes (9).  ot-DaTX  is  a  less  potent  inhibitor  of PK,v, 
whereas IbTX blocks neither PK,v nor PK,Ca. The rank order 
of potency of these peptides is identical in affecting each of 
the T  cell parameters studied: (a) inhibition of 125I-ChTX 
binding to human T lymphocytes; (b) proliferation; (c) lym- 
phokine  production;  and  (d)  interference with  a  rise  in 
[CF +  ]i. Therefore, it can be concluded that blockade of PK,v 
is the relevant target for inhibition of the phenomena inves- 
tigated in this study. 
The role of PK,C, in human T cells remains unclear.  T cell 
activation by mitogen (27, 28), anti-CD3 (13), or ionomycin 
(29) is accompanied by membrane hyperpolarization. Hyper- 
polarization has been suggested to be a consequence of the 
activation of Pz,c, secondary to the increase in [Ca2+]i, and 
ChTX was thought to exert its antiproliferative effect by in- 
hibiting Pz,c, (27).  Results in this study, however, suggest 
that  PK,V, through  its  ability  to  set  resting  potential  of 
T lymphocytes, is the most relevant target for the action of 
the peptides. It is not known whether a selective inhibitor 
of PK,c, would have a similar spectrum of immunosuppres- 
sive activities as a PK,V blocker, since such pharmacological 
probes have not,  as yet, been identified. 
It is well known that a rise in [CF +  ]i is a necessary step 
in the T cell activation cascade. Although it is generally agreed 
that the early phase of calcium elevation is associated with 
release of calcium from internal stores, calcium from external 
sources also contributes to the early phase of calcium eleva- 
tion. Data obtained by us and others (30) show that in the 
presence of EGTA (to remove extracellular calcium), the early 
phase of calcium elevation induced by anti-CD3 was inhibited 
and subsequently, T cell activation measured by IL-2 RNA 
transcription (31) or proliferation (32) was also inhibited. These 
data indicate that a large portion of the early phase of cal- 
cium elevation comes from the extracellular source, and that 
blocking the early phase can lead to the inhibition of T cell 
activation. In this study we demonstrated that ChTX inhibits 
the early phase of Ca  2  + elevation. Whether ChTX inhibits 
calcium release or calcium influx, or both is not presently 
known. The current studies also do not allow us to address 
the role of intracellular Ca  2+ stores vs. influx in eliciting the 
rise in [Ca2+]i directly. Nevertheless, the observation that 
both  the  TCR-induced  and  ionomycin-mediated rise  in 
[CaZ+]i are blocked by the toxins suggest that Pz,v is an im- 
portant determinant in controlling T cell Ca  z + homeostasis. 
How does inhibition  of PK,V affect the rise in [Ca2+]i? 
Depolarization of the T cell, whether mediated by blockade 
of PK,v or by incubation in high K § solution, is sufficient 
to inhibit the rise in [CaZ§  Indeed, ChTX,  NxTX,  and 
MgTX have recently been shown to depolarize resting lym- 
phocytes (9). The observation that cellular depolarization in- 
hibits  the mitogen-induced elevation of [CaZ+]i has been 
made previously (10-13),  but these earlier studies had not 
related their finding to blockade of PK,V. It is not clear why 
the effects of ionomycin are also inhibited by ChTX since 
the ionophore is electroneutral. It is possible that depolariza- 
tion of the membrane potential by ChTX leads to inhibition 
of ionomycin-mediated release of intracellular CF +.  That 
depolarization inhibits ionomycin-induced [Ca2+]i was re- 
ported earlier (29).  Perhaps an internal negative membrane 
potential  drives influx of Ca  2+  into  lymphocytes and de- 
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and out of intracellular stores, limiting Ca  2+  influx, while 
allowing cellular Ca  2+  efflux to occur,  will eventually de- 
crease the amount of intracellular Ca  2§  supplies.  In such a 
model, intracellular Ca  2+  stores  would be in equilibrium 
with the resting potential, and depolarization would make 
this Ca  2+ pool unavailable for release after mitogen stimu- 
lation. 
In conclusion, this investigation provides a mechanistic basis 
for the previously observed immunosuppressive effects  of 
ChTX. We have confirmed and extended results indicating 
that  ChTX  inhibits  T  cell  proliferation and lymphokine 
production when triggered through Ca2+-associated  signal 
transduction pathways. Moreover, similar data have been ob- 
tained with PK,v selective peptides,  suggesting that blockade 
of PK,v, because  of its role in setting the resting potential 
in T lymphocytes, leads to inhibition of the activation-induced 
rise in [Ca2+]i. The precise mechanism by which changes in 
membrane potential result in alterations in Ca  2+ homeostasis 
remains to be determined. It will also be interesting to deter- 
mine the relevance of PK,V as a target for inhibition of im- 
mune responsiveness  in vivo. 
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